A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)

BACKGROUND: Clostridium difficile is the most common cause of hospital-acquired infections, responsible for >450000 infections annually in the USA. Probiotics provide a promising, well-tolerated adjunct therapy to standard C. difficile infection (CDI) treatment regimens, but there is a paucity of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Barker, Anna K, Duster, Megan, Valentine, Susan, Hess, Timothy, Archbald-Pannone, Laurie, Guerrant, Richard, Safdar, Nasia
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890711/
https://ncbi.nlm.nih.gov/pubmed/28961980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx254
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados